title: Selective cell death mediated by small conditional RNAs.
abstract: Cancer cells are characterized by genetic mutations that deregulate cell proliferation and suppress cell death. To arrest the uncontrolled replication of malignant cells, conventional chemotherapies systemically disrupt cell division, causing diverse and often severe side effects as a result of collateral damage to normal cells. Seeking to address this shortcoming, we pursue therapeutic regulation that is conditional, activating selectively in cancer cells. This functionality is achieved using small conditional RNAs that interact and change conformation to mechanically transduce between detection of a cancer mutation and activation of a therapeutic pathway. Here, we describe small conditional RNAs that undergo hybridization chain reactions (HCR) to induce cell death via an innate immune response if and only if a cognate mRNA cancer marker is detected within a cell. The sequences of the small conditional RNAs can be designed to accept different mRNA markers as inputs to HCR transduction, providing a programmable framework for selective killing of diverse cancer cells. In cultured human cancer cells (glioblastoma, prostate carcinoma, Ewing's sarcoma), HCR transduction mediates cell death with striking efficacy and selectivity, yielding a 20- to 100-fold reduction in population for cells containing a cognate marker, and no measurable reduction otherwise. Our results indicate that programmable mechanical transduction with small conditional RNAs represents a fundamental principle for exploring therapeutic conditional regulation in living cells.
authors.affiliation: Department of Bioengineering, California Institute of Technology, Pasadena, CA 91125, USA.
authors.forename: Suvir
authors.initials: S
authors.lastname: Venkataraman
authors.forename: Robert M
authors.initials: RM
authors.lastname: Dirks
authors.forename: Christine T
authors.initials: CT
authors.lastname: Ueda
authors.forename: Niles A
authors.initials: NA
authors.lastname: Pierce
mesh_terms: D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000235:genetics; D002470:Cell Survival; D006801:Humans; D006824:Hybridization, Genetic; D007113:Immunity, Innate; D040542:Mechanotransduction, Cellular; D035683:MicroRNAs / Q000235:genetics / Q000627:therapeutic use*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D014161:Transduction, Genetic; D014407:Tumor Cells, Cultured
chemical_list: D014408:Biomarkers, Tumor; D035683:MicroRNAs
references.citation: Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):75-86
references.pmid: 17449137
references.citation: Small. 2005 Mar;1(3):284-99
references.pmid: 17193445
references.citation: Nat Rev Cancer. 2004 Mar;4(3):177-83
references.pmid: 14993899
references.citation: Cancer Res. 1996 Feb 15;56(4):728-32
references.pmid: 8631004
references.citation: Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15275-8
references.pmid: 15492210
references.citation: Cancer Res. 2005 Oct 1;65(19):8984-92
references.pmid: 16204072
references.citation: Pharmacol Ther. 1992;54(3):307-17
references.pmid: 1465480
references.citation: Virology. 1997 Sep 29;236(2):354-63
references.pmid: 9325243
references.citation: Nature. 2009 Jan 22;457(7228):396-404
references.pmid: 19158785
references.citation: N Engl J Med. 1984 Aug 30;311(9):584-5
references.pmid: 6749231
references.citation: Science. 1988 Apr 8;240(4849):210-3
references.pmid: 3281258
references.citation: EMBO Mol Med. 2010 May;2(5):146-58
references.pmid: 20432502
references.citation: Cell Death Differ. 2009 Aug;16(8):1093-107
references.pmid: 19373242
references.citation: Nature. 2009 Jan 22;457(7228):426-33
references.pmid: 19158789
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7727-31
references.pmid: 8052651
references.citation: Cancer Res. 1996 Nov 1;56(21):5079-86
references.pmid: 8895767
references.citation: Oncogene. 2003 Jun 12;22(24):3721-33
references.pmid: 12802279
references.citation: Nat Biotechnol. 2002 Sep;20(9):895-900
references.pmid: 12205508
references.citation: Nat Nanotechnol. 2007 Aug;2(8):490-4
references.pmid: 18654346
references.citation: Nucleic Acids Res. 1994 Dec 11;22(24):5506-7
references.pmid: 7816645
references.citation: Genes Dev. 1999 Dec 15;13(24):3280-93
references.pmid: 10617576
references.citation: J Virol. 1993 Dec;67(12):7695-700
references.pmid: 7693978
references.citation: Endocr Relat Cancer. 2001 Jun;8(2):83-96
references.pmid: 11397666
references.citation: Mol Cell Biol. 1992 Nov;12(11):5238-48
references.pmid: 1357546
references.citation: J Biol Chem. 2001 Jul 6;276(27):24946-58
references.pmid: 11337501
references.citation: Oncogene. 2001 Sep 10;20(40):5747-54
references.pmid: 11607824
references.citation: Nature. 1998 Feb 19;391(6669):806-11
references.pmid: 9486653
references.citation: Nature. 2010 Apr 15;464(7291):1067-70
references.pmid: 20305636
references.citation: Nature. 2000 Aug 10;406(6796):605-8
references.pmid: 10949296
references.citation: Nat Nanotechnol. 2007 May;2(5):275-84
references.pmid: 18654284
references.citation: Biochimie. 2007 Jun-Jul;89(6-7):799-811
references.pmid: 17451862
references.citation: J Interferon Res. 1993 Oct;13(5):323-8
references.pmid: 7905506
references.citation: Cell. 2005 Sep 23;122(6):901-13
references.pmid: 16179259
references.citation: Science. 2005 Jun 3;308(5727):1424-8
references.pmid: 15933191
references.citation: Mol Cell Biol. 1987 Apr;7(4):1568-71
references.pmid: 3600637
references.citation: Mol Ther. 2005 Nov;12(5):969-75
references.pmid: 16084774
references.citation: Biochimie. 2002 Sep;84(9):925-44
references.pmid: 12458085
references.citation: J Biol Chem. 2006 Jul 28;281(30):21458-21468
references.pmid: 16717090
references.citation: Virology. 1990 May;176(1):106-13
references.pmid: 2330670